文献速递血栓与止血

大剂量静脉注射免疫球蛋白G与常规肝素抗凝用于一例重症自身免疫性肝素诱导性血小板减少症患者的急诊心脏手术

High-dose intravenous immunoglobulin G and usual heparin anticoagulation for urgent cardiac surgery in a patient with severe autoimmune heparin-induced thrombocytopenia.
PubMed 文献 · J Thromb Haemost · 2024-11-16

一例56岁女性因缓症链球菌二尖瓣感染性心内膜炎并发重症自身免疫性肝素诱导性血小板减少症(aHIT)需急诊心脏手术。作者在术前给予大剂量静脉注射免疫球蛋白G(IVIG;1 g/kg×2)后术中使用肝素,未发生术中或术后血栓形成。系列血清素释放试验显示,IVIG后在使用心脏手术中典型肝素浓度(2-5 U/mL)时血小板活化程度极低(约30%血清素释放),显著低于IVIG前无肝素时(约85%血清素释放)。

要点

  • 急诊心脏手术前大剂量IVIG(1 g/kg×2)后使用标准术中肝素剂量,未发生术中或术后血栓形成。
  • IVIG后心脏手术典型肝素浓度(2-5 U/mL)下血清素释放约30%,低于IVIG前无肝素时约85%。
  • 作者认为术前大剂量IVIG似乎可减少HIT(包括aHIT)抗体经肝素诱导的血小板活化效应。

核心结论

  • 在急诊心脏手术情形下,术前大剂量IVIG似乎是减少HIT(包括aHIT)抗体所致血小板活化效应的合理策略,使标准术中肝素剂量得以安全使用。

研究设计与样本

  • 一例56岁女性因缓症链球菌二尖瓣感染性心内膜炎并发重症aHIT需急诊心脏手术的病例报告。

主要发现

  • 患者在给予大剂量IVIG(1 g/kg×2)后接受肝素抗凝心脏手术,未发生术中或术后血栓形成。
  • 系列血清素释放试验(使用IVIG前/后血样)显示:IVIG后心脏手术典型肝素浓度(2-5 U/mL)下血小板活化极低(约30%血清素释放),显著低于IVIG前无肝素时(约85%血清素释放)。

关键数值与推荐

  • IVIG剂量为1 g/kg×2。
  • 心脏手术中典型肝素浓度为2-5 U/mL。
  • IVIG后该肝素浓度下血清素释放约30%,IVIG前无肝素时约85%。

临床怎么用

  • 作者认为,在急诊心脏手术前给予大剂量IVIG可减少HIT(包括aHIT)抗体经肝素诱导的血小板活化效应,使标准术中肝素剂量得以安全使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 56-year-old woman required urgent cardiac surgery for Streptococcus mitis mitral valve infective endocarditis complicated by severe autoimmune heparin-induced thrombocytopenia (aHIT). We reasoned that the combination of high-dose intravenous immunoglobulin G (IVIG; to mitigate aHIT antibody-mediated platelet activation in the presence of heparin) together with the high concentrations of heparin attained during cardiac surgery (which typically produces less platelet activation in vitro vs usual therapeutic heparin concentrations) might prove effective. Accordingly, our patient underwent cardiac surgery with heparin following high-dose IVIG (1 g/kg × 2) without intra- or postoperative thrombosis. Serial serotonin release assays, using blood obtained pre-/post-IVIG, showed minimal platelet activation (∼30% serotonin release) post-IVIG at heparin concentrations typically obtained during cardiac surgery (2-5 U/mL) and significantly less than pre-IVIG serum in heparin's absence (∼85% serotonin release). In the setting of urgent cardiac surgery, preoperative high-dose IVIG appears to be a reasonable strategy to reduce platelet-activating effects of heparin-induced thrombocytopenia (including aHIT) antibodies, permitting safe use of standard intraoperative heparin dosing.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Warkentin TE, Geerts W, Sheppard JI, et al. High-dose intravenous immunoglobulin G and usual heparin anticoagulation for urgent cardiac surgery in a patient with severe autoimmune heparin-induced thrombocytopenia. J Thromb Haemost. 2024. PMID: 39551436. doi:10.1016/j.jtha.2024.10.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。